Yao(Y),Xu(Z),Ding(H),Zhu(Y),Yang(SS),Wang(... J Nanobiotechnology 2026-04-05

...ELNs from the medicinal plant yam (Yam ELNs). Structural analysis revealed that Yam ELNs possess a homogeneous bilayer m...

Zhang(YQ),Nie(R),Feng(ZY),Fan(MH),Shen(ZX)... Bioact Mater 2026-08-00

...ELNs) and decellularized small intestinal submucosa matrix-modified hydrogel (SM). In vitro experiments demonstrated tha...

Kewan(T),Alkabbani(O),Zureigat(H),He(R),Je... Blood Neoplasia 2026-05-00

...ELN 2022 (0.640) and Beat AML 2024 (0.635) over ELN 2024 (0.601). For patients treated with IC, ELN 2022 (0.680) and Bea...

Dong(Y),Yuan(Q),Chen(C),Zhang(Z) Oncol Lett 2026-05-00

...ELNs (PELNs) in anti-CRC therapy. PELNs were successfully extracted via the ultra-centrifugation method and were effecti...

Silver(RT),Hasselbalch(HC) Leukemia 2026-06-00

...ELN-defined low and high-risk disease; the ELN suggested criteria for using rIFNα in low-risk patients if certain issues...

Chai(Y),Bono(KAM),Tang(NX),Ooi(MG),Jen(WY)... Cancer Cell Int 2026-04-08

...ELN), use cytogenetic and molecular markers to guide treatment decisions, their predictive accuracy remains suboptimal, ...

Thompson(JD),Fisher(MB) bioRxiv 2026-05-15

...ELN, TNMD), suggesting active matrix synthesis, while post-pubescent ACLs showed elevated secondary matrix genes (COL3A1...

Ambinder(A),Levis(M),Wang(X),Pratz(K),Matt... Leuk Res 2026-05-00

...ELN) 2022 risk, high risk mutations (TP53, ASXL1, RUNX1), receipt of cytoreduction, or specific HMA agent used between t...

Cadena(M),Casado(M),Gómez-Ambrosi(J),Ramír... Clin Sci (Lond) 2026-04-15

...ELN, MMP9; P <0.01) and enhancing acute inflammatory mediators (IL1B, IL6; P <0.01), tight-junction proteins (CLDN1; P <...

Dixon(AJ),Mohanty(I),Kaur(G),McCormick(JA)... Am J Physiol Renal Physiol 2026-05-01

...ELN). Heterozygous deletion of Eln (Eln+/-) in mice recapitulates hypertension and arteriopathy associated with WS. Prev...